148 related articles for article (PubMed ID: 18041673)
1. AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 1.
Searle B
IDrugs; 2007 Dec; 10(12):833-5. PubMed ID: 18041673
[No Abstract] [Full Text] [Related]
2. EORTC-NCI-AACR--20th symposium molecular targets and cancer therapeutics: mechanisms of targeting for cancer treatment.
Fakorede A
IDrugs; 2008 Dec; 11(12):857-8. PubMed ID: 19051142
[No Abstract] [Full Text] [Related]
3. AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 3.
Collins T
IDrugs; 2007 Dec; 10(12):840-3. PubMed ID: 18041675
[No Abstract] [Full Text] [Related]
4. AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 4.
Eccles SA
IDrugs; 2007 Dec; 10(12):844-7. PubMed ID: 18041676
[No Abstract] [Full Text] [Related]
5. AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 2.
Searle B; Collins T
IDrugs; 2007 Dec; 10(12):836-9. PubMed ID: 18041674
[No Abstract] [Full Text] [Related]
6. EORTC-NCI-AACR - 18th Symposium - Molecular Targets and Cancer Therapeutics. New approaches in treating cancer.
Murch L
IDrugs; 2007 Jan; 10(1):8-10. PubMed ID: 17187304
[No Abstract] [Full Text] [Related]
7. EORTC-NCI-AACR - 18th Symposium - Molecular Targets and Cancer Therapeutics.
Kibble A
IDrugs; 2007 Jan; 10(1):1-2. PubMed ID: 17187301
[No Abstract] [Full Text] [Related]
8. EORTC-NCI-AACR - 18th Symposium - Molecular Targets and Cancer Therapeutics. Updates on cancer drugs.
Kibble A
IDrugs; 2007 Jan; 10(1):3-4. PubMed ID: 17187302
[No Abstract] [Full Text] [Related]
9. AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 2.
Walker K; Padhiar M
IDrugs; 2010 Jan; 13(1):10-2. PubMed ID: 20024839
[TBL] [Abstract][Full Text] [Related]
10. Aurora kinases dawn as cancer drug targets.
Sausville EA
Nat Med; 2004 Mar; 10(3):234-5. PubMed ID: 14991042
[No Abstract] [Full Text] [Related]
11. AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 1.
Walker K; Padhiar M
IDrugs; 2010 Jan; 13(1):7-9. PubMed ID: 20024838
[TBL] [Abstract][Full Text] [Related]
12. EORTC-NCI-AACR--20th symposium molecular targets and cancer therapeutics.
Din S
IDrugs; 2008 Dec; 11(12):855-6. PubMed ID: 19051141
[No Abstract] [Full Text] [Related]
13. American Association for Cancer Research--99th Annual Meeting. Clinical and preclinical data on promising therapeutics.
Karger GA; Lee W
IDrugs; 2008 Jun; 11(6):415-7. PubMed ID: 18509781
[No Abstract] [Full Text] [Related]
14. [16th EORTC-NCI-AACR symposium on new molecular targets and cancer therapeutics].
Lavelle F;
Bull Cancer; 2004 Dec; 91(12):985-8. PubMed ID: 15634640
[No Abstract] [Full Text] [Related]
15. [The serine/threonine kinases that control cell cycle progression as therapeutic targets].
Diallo A; Prigent C
Bull Cancer; 2011 Nov; 98(11):1335-45. PubMed ID: 22020767
[TBL] [Abstract][Full Text] [Related]
16. PLK1 inhibitors: setting the mitotic death trap.
Plyte S; Musacchio A
Curr Biol; 2007 Apr; 17(8):R280-3. PubMed ID: 17437704
[TBL] [Abstract][Full Text] [Related]
17. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part III.
Sovran L
IDrugs; 2007 Jun; 10(6):362-5. PubMed ID: 17641995
[No Abstract] [Full Text] [Related]
18. AACR-NCI-EORTC--17th Symposium: Molecular Targets and Cancer Therapeutics.
Garvey R
IDrugs; 2006 Feb; 9(2):90-2. PubMed ID: 16523394
[No Abstract] [Full Text] [Related]
19. Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics.
Chopra P; Sethi G; Dastidar SG; Ray A
Expert Opin Investig Drugs; 2010 Jan; 19(1):27-43. PubMed ID: 20001553
[TBL] [Abstract][Full Text] [Related]
20. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
